How we invest - Eckuity

Capital that Translates

Great science into

tomorrow’s Healthcare

Eckuity Capital is a healthcare-focused growth equity investor targeting established, middle-market companies with regulatory approval, commercial traction, and scalable operating models. We deploy structured minority investments designed to support disciplined growth while maintaining alignment with founders and management teams. We invest across three core verticals: MedTech, HealthTech, and Biotech Services. Our focus spans differentiated medical technologies and diagnostics, technology-enabled healthcare services, and critical infrastructure supporting research, development, and clinical execution.

Beyond capital, we provide strategic support focused on commercialization, market expansion, and long-term positioning. Through our network of healthcare operators, strategic acquirers, and institutional investors, we assist portfolio companies in executing growth initiatives and preparing for successful strategic or public market outcomes.

Standard of Care,

Redefined

Our investment approach emphasizes capital efficiency, operational scalability, and multiple paths to liquidity. We seek businesses with durable competitive positions, clear value creation levers, and the ability to benefit from secular growth trends across the global healthcare system.

Impact ON HEALTHCARE

Better outcomes

Better outcomes means an improvement on the current ability to treat or manage a disease or condition. Better outcomes can be achieved either by increasing efficacy or improving efficiency over a current treatment or by developing an entirely new treatment for a currently untreatable disease. Better outcomes can also be achieved by developing new treatments with lower side-effects. Side effects cause treatment drop-outs or limit who can benefit.

Wider access

Treatments are often available but with limited access to a small number of people. We look for ways to broaden access:

Distribution – creating new access points for patients like secure online delivery, telemedicine and digital therapeutics.

Formulation enhancements can lead to greater access by making treatment simpler. A pill taken at home is more accessible than having to wait for a specialist hospital-based team for surgery.

Data and AI can be used to better understand who will benefit most from a treatment, creating greater access.

Lower cost

Cost reduction can take many forms: lower manufacturing costs to eliminating the need to refrigerate storage, to reducing the cost of giving the treatment eg a pill cost less to administer than an intravenous infusion.
The cost to develop a new drug/treatment is rising exponentially, however new technology, data and AI can speed discovery, identify the precise patients for treatment to reduce the size of clinical trials and reduce the risk of costly failures.

A culture for good

We look for management and founders that not only make impact part of their business delivery but also build impact values into their culture and business practices. We believe companies play a vital role in society as engines of creativity, innovation and economic opportunity, as well as shaping the future of sustainability.

Business with purpose

We support the Businesses with Purpose movement and encourage our partners to: Deliver value to the market, Invest in employees, Deal fairly and ethically with suppliers, Support the communities in which they work and Generate long-term value for shareholders.

Responsible development

We look for companies that are developing products that keep both environmental and human safety in mind. We ensure they contribute to practices that help conserve resources like water and energy or that actively build sustainability into their business models in the form of recycling/waste programs, carbon offsetting and ecofriendly development.